SEC Form 4 · accession 0001682852-26-000176
Moderna, Inc. · MRNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen Hoge
Officer — President
Period of report
Sep 14, 2026
Accepted (ET)
Sep 16, 2026 · 4:48 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001682852
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 14, 2026 | M | 76,453 | $12.21 | A | 1,566,152 | D | |
| Common StockF2 | Sep 14, 2026 | S | 40,294 | $144.13 | D | 1,525,858 | D | |
| Common Stock | Sep 15, 2026 | M | 76,452 | $12.21 | A | 1,602,310 | D | |
| Common StockF3 | Sep 15, 2026 | S | 40,281 | $146.07 | D | 1,562,029 | D | |
| Common Stock | holding | — | — | — | 4,116 | I | By Valhalla, LLC | |
| Common StockF4 | holding | — | — | — | 151,933 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F5 | $12.21 | Sep 14, 2026 | M | 76,453 | D | — | Feb 23, 2027 | Common Stock | 76,453 | 382,262 | D |
| Stock Option (Right to Buy)F5 | $12.21 | Sep 15, 2026 | M | 76,452 | D | — | Feb 23, 2027 | Common Stock | 76,452 | 305,810 | D |
Explanation of responses
- F1The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on June 15, 2026.
- F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $143.99 to $144.66. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $145.97 to $146.27. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- F4These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
- F5This option is fully vested and exercisable.